Atlas Trials

A Phase I Study to Assess the Effect of Itraconazole and Rifampicin on Pharmacokinetics Profile of BPI-7711

Clinical trial NCT04135833 · COMPLETED

Trial details

NCT number
NCT04135833
Sponsor
Beta Pharma, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
NSCLC
Start date
2019-12-12
Primary completion
2020-07-22
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.